Page 1 Date 11 November 2020 Re: Management Discussion & Analysis for the 9-months period Ended 30 September 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
- Translation - 11 November 2019 Subject: Management’s Discussion and Analysis for the Operating Results of the 3 rd Quarter of 2019 Attention: The President of the Stock Exchange of Thailand Exotic
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
No. ACC6311/010 12 November, 2020 Subject Clarify the Operating results for quarter 3/2020 ended 30 September, 2020 Attention Director and Manager The Stock Exchange of Thailand According to Advanced
Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to
Page 1 of 3 No. ACC6308/001 August 11, 2021 Subject: Clarification of the operating results quarter 2/2021 of the year ended June 30, 2021 Attention : Director and Managing Director, The Stock
Page 1 of 3 No. ACC6411/003 November 11, 2021 Subject: Clarification of the operating results quarter 3/2021 of the year ended September 30, 2021 Attention : Director and Managing Director, The Stock